undamentalytics Newsletter

Axogen vs Cerus

Axogen and Cerus are similar in size: $225m and $234m of revenue in their latest fiscal years. Axogen grew faster (20.2% against 16.1%). Cerus kept more of each dollar of sales as profit: a net margin of -6.7% against -7.0%. Axogen carries less debt relative to equity (37.6% against 130.7%).

Latest fiscal yearAxogenAXGN, 2025CerusCERS, 2025
Revenue $225m $234m
Revenue growth 20.2% 16.1%
Net income −$15.7m −$15.6m
Operating margin -3.5% -3.7%
Net margin -7.0% -6.7%
Return on equity -13.5% -26.0%
Free cash flow −$2.9m $1.1m
Cash $35.5m $20.0m
Total debt $48.4m $84.0m
Debt to equity 37.6% 130.7%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 622 275
Market value $2.95bn $472m
Price vs our value range — —
Moat score 31 (Weak) 21 (Weak)
Insider trades, 12 months 0 buys, 0 sales 0 buys, 25 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.